2012
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells.
Kubicek S,
Gilbert JC,
Fomina-Yadlin D,
Gitlin AD,
Yuan Y,
Wagner FF,
Holson EB,
Luo T,
Lewis TA,
Taylor B,
Gupta S,
Shamji A,
Wagner BK,
Clemons PA,
Schreiber S.
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells. PNAS 2012 Apr 3;109(14):5364-9.
2012
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Kotlarz D,
Beier R,
Murugan D,
Diestelhorst J,
Jensen O,
Boztug K,
Pfeifer D,
Kreipe H,
Pfister ED,
Baumann U,
Puchalka J,
Bohne J,
Egritas O,
Dalgic B,
Kolho KL,
Sauerbrey A,
Buderus S,
Güngör T,
Enninger A,
Koda YK,
Guariso G,
Weiss B,
Corbacioglu S,
Socha P,
Uslu N,
Metin A,
Wahbeh GT,
Husain K,
Ramadan D,
Al-Herz W,
Grimbacher B,
Sauer M,
Sykora KW,
Koletzko S,
Klein C.
Gastroenterology. 2012 Aug;143(2):347-55.
2012
A downstream CpG island controls transcript initiation and elongation and the methylation state of the imprinted Airn macro ncRNA promoter.
Koerner MV,
Pauler FM,
Hudson QJ,
Santoro F,
Sawicka A,
Guenzl PM,
Stricker SH,
Schichl YM,
Latos PA,
Klement RM,
Warczok KE,
Wojciechowski J,
Seiser C,
Kralovics R,
Barlow DP.
PLoS Genet. 2012;8(3):e1002540. Epub 2012 Mar 1.
2012
Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression, Mol.
Kachaner D,
Filipe J,
Laplantine E,
Bauch A,
Bennett KL,
Superti-Furga G,
Israël A,
Weil R.
Cell. 45, 553-66.
2012
Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis.
Hopkins S,
Linderoth E,
Hantschel O,
Suarez-Henriques P,
Pilia G,
Kendrick H,
Smalley MJ,
Superti-Furga G,
Ferby I.
Dev Cell. 2012 Sep 11;23(3):547-59.
2012
Role of germline genetic factors in MPN pathogenesis.
Harutyunyan AS,
Kralovics R.
Hematol Oncol Clin North Am. 2012 Oct;26(5):1037-51.
2012
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia.
Hantschel O,
Warsch W,
Eckelhart E,
Kaupe I,
Grebien F,
Wagner KU,
Superti-Furga G,
Sexl V.
Nat Chem Biol. 2012 Jan 29;8(3):285-93.
2012
Cell biology: a key driver of therapeutic innovation.
Hantschel O,
Superti-Furga G.
J Cell Biol. 2012 Nov 12;199(4):571-5.
2012
The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL.
Hantschel O,
Grebien F,
Superti-Furga G.
Cancer Res. 2012 Oct 1;72(19):4890-5.
2012
EpiExplorer: live exploration and global analysis of large epigenomic datasets.
Halachev K,
Bast H,
Albrecht F,
Lengauer T,
Bock C.
Genome Biol. 2012 Oct 3;13(10):R96.
